143 related articles for article (PubMed ID: 29449053)
1. Genetic and epigenetic alterations in the tumour, tumour margins, and normal buccal mucosa of patients with oral cancer.
Eljabo N; Nikolic N; Carkic J; Jelovac D; Lazarevic M; Tanic N; Milasin J
Int J Oral Maxillofac Surg; 2018 Aug; 47(8):976-982. PubMed ID: 29449053
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas.
Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
Oral Oncol; 2011 Aug; 47(8):702-8. PubMed ID: 21697000
[TBL] [Abstract][Full Text] [Related]
3. Molecular staging of surgical margins in oral squamous cell carcinoma using promoter methylation of p16(INK4A), cytoglobin, E-cadherin, and TMEFF2.
Shaw RJ; Hobkirk AJ; Nikolaidis G; Woolgar JA; Triantafyllou A; Brown JS; Liloglou T; Risk JM
Ann Surg Oncol; 2013 Aug; 20(8):2796-802. PubMed ID: 23111707
[TBL] [Abstract][Full Text] [Related]
4. Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa.
Kato K; Hara A; Kuno T; Mori H; Yamashita T; Toida M; Shibata T
J Cancer Res Clin Oncol; 2006 Nov; 132(11):735-43. PubMed ID: 16791592
[TBL] [Abstract][Full Text] [Related]
5. The correlations between alteration of p16 gene and clinicopathological factors and prognosis in squamous cell carcinomas of the buccal mucosa.
Dong Y; Wang J; Dong F; Wang X; Zhang Y
J Oral Pathol Med; 2012 Jul; 41(6):463-9. PubMed ID: 22429295
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation profiling revealed promoter hypermethylation-induced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinoma.
Khor GH; Froemming GR; Zain RB; Abraham MT; Omar E; Tan SK; Tan AC; Vincent-Chong VK; Thong KL
Int J Med Sci; 2013; 10(12):1727-39. PubMed ID: 24155659
[TBL] [Abstract][Full Text] [Related]
7. Aberrant gene promoter methylation of E-cadherin, p16
Burassakarn A; Pientong C; Sunthamala N; Chuerduangphui J; Vatanasapt P; Patarapadungkit N; Kongyingyoes B; Ekalaksananan T
Med Oncol; 2017 Jul; 34(7):128. PubMed ID: 28573642
[TBL] [Abstract][Full Text] [Related]
8. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
[TBL] [Abstract][Full Text] [Related]
9. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.
Shaw RJ; Liloglou T; Rogers SN; Brown JS; Vaughan ED; Lowe D; Field JK; Risk JM
Br J Cancer; 2006 Feb; 94(4):561-8. PubMed ID: 16449996
[TBL] [Abstract][Full Text] [Related]
10. The prognostic implications of the surgical margin in oral squamous cell carcinoma.
Sutton DN; Brown JS; Rogers SN; Vaughan ED; Woolgar JA
Int J Oral Maxillofac Surg; 2003 Feb; 32(1):30-4. PubMed ID: 12653229
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic signatures of local recurrence in oral squamous cell carcinoma.
Ghantous Y; Bahouth Z; Abu El-Naaj I
Arch Oral Biol; 2018 Nov; 95():141-148. PubMed ID: 30118965
[TBL] [Abstract][Full Text] [Related]
12. Concurrent hypermethylation of multiple regulatory genes in chewing tobacco associated oral squamous cell carcinomas and adjacent normal tissues.
Kulkarni V; Saranath D
Oral Oncol; 2004 Feb; 40(2):145-53. PubMed ID: 14693237
[TBL] [Abstract][Full Text] [Related]
13. Detection of p16 promoter methylation in the serum of oral cancer patients.
Nakahara Y; Shintani S; Mihara M; Hino S; Hamakawa H
Int J Oral Maxillofac Surg; 2006 Apr; 35(4):362-5. PubMed ID: 16298513
[TBL] [Abstract][Full Text] [Related]
14. ORAOV1 is amplified in oral squamous cell carcinoma.
Xavier FC; Rodini CO; Paiva KB; Destro MF; Severino P; Moyses RA; ; Tajara EH; Nunes FD
J Oral Pathol Med; 2012 Jan; 41(1):54-60. PubMed ID: 21623924
[TBL] [Abstract][Full Text] [Related]
15. Somatic genomic imbalances in 'tumour-free' surgical margins of oral cancer.
Baldan F; Gnan C; Lazarevic M; Nikolic N; Mio C; Tepavcevic Z; Robiony M; Milasin J; Damante G
Int J Oral Maxillofac Surg; 2023 Aug; 52(8):831-838. PubMed ID: 36639343
[TBL] [Abstract][Full Text] [Related]
16. Cancer of the buccal mucosa: are margins and T-stage accurate predictors of local control?
Sieczka E; Datta R; Singh A; Loree T; Rigual N; Orner J; Hicks W
Am J Otolaryngol; 2001; 22(6):395-9. PubMed ID: 11713724
[TBL] [Abstract][Full Text] [Related]
17. Assessing immuno-expression of p53 protein and TP 53 gene amplification in histologically negative surgical margins of oral squamous cell carcinoma patients and normal oral mucosa.
Kamat MS; Puranik RS; Das Rai AB; Patil BR; Patil S
Clin Oral Investig; 2022 Oct; 26(10):6235-6243. PubMed ID: 35674840
[TBL] [Abstract][Full Text] [Related]
18. A Noninvasive Test for MicroRNA Expression in Oral Squamous Cell Carcinoma.
Gissi DB; Morandi L; Gabusi A; Tarsitano A; Marchetti C; Cura F; Palmieri A; Montebugnoli L; Asioli S; Foschini MP; Scapoli L
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914173
[TBL] [Abstract][Full Text] [Related]
19. Alu hypomethylation in smoke-exposed epithelia and oral squamous carcinoma.
Puttipanyalears C; Subbalekha K; Mutirangura A; Kitkumthorn N
Asian Pac J Cancer Prev; 2013; 14(9):5495-501. PubMed ID: 24175848
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of the RECK gene predicts poor prognosis in oral squamous cell carcinomas.
Long NK; Kato K; Yamashita T; Makita H; Toida M; Hatakeyama D; Hara A; Mori H; Shibata T
Oral Oncol; 2008 Nov; 44(11):1052-8. PubMed ID: 18485791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
